C07D 225/08
Condensed with two six-membered rings
Official title: condensed with two six-membered rings
C07D225/08 (Condensed with two six-membered rings) appears on 98 US grants and 76 published applications in this corpus.
Search patents in C07D- Granted patents
- 98
- Published applications
- 76
- Assignees
- 56
- Inventors
- 226
- Latest grant
- 2 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 12 | 5 |
| 2003 | 3 | 13 |
| 2004 | 13 | 0 |
| 2005 | 2 | 1 |
| 2006 | 1 | 1 |
| 2007 | 1 | 2 |
| 2008 | 1 | 3 |
| 2009 | 1 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 4 |
| 2013 | 2 | 2 |
| 2014 | 3 | 6 |
| 2015 | 5 | 4 |
| 2016 | 3 | 5 |
| 2017 | 4 | 3 |
| 2018 | 0 | 5 |
| 2019 | 5 | 1 |
| 2020 | 1 | 4 |
| 2021 | 4 | 2 |
| 2022 | 2 | 2 |
| 2023 | 0 | 3 |
| 2024 | 4 | 3 |
| 2025 | 3 | 2 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Macrocycles as factor xia inhibitors2 Sep 2025US 12,404,274 B2Bristol-Myers Squibb Company
- Molecular degraders of extracellular proteins25 Feb 2025US 12,234,256 B2Yale University
- Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as LXR agonists28 Jan 2025US 12,209,180 B2Regeneron Pharmaceuticals, Inc.
- Process for the cycloaddition of a (hetero)aryl 1,3-dipole compound with a (hetero)cycloalkyne10 Sep 2024US 12,084,448 B2Synaffix B.V.
- Non-chromatographic purification of macrocyclic peptides by a resin catch and release25 Jun 2024US 12,018,097 B2Bristol-Myers Squibb Company
- Spiromacrocyclic orexin 2 receptor agonists28 May 2026US 2026/0144795 A1H. Lundbeck A.S.
- Molecular degraders of extracellular proteins7 May 2026US 2026/0125410 A1
- Functionalized Conjugation Crosslinkers and Uses Thereof1 Jan 2026US 2026/0001840 A1Azvlz, Inc.
- Molecular degraders of extracellular proteins25 Dec 2025US 2025/0388614 A1
- Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr agonists29 May 2025US 2025/0171622 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents
- Process for the cycloaddition of a halogenated 1,3-dipole compound with a (hetero)cycloalkyne65US 10,266,502 B2Synaffix B.V. · 2019
- Tricyclic benzazepine vasopressin antagonists50US 5,512,563 AAmerican Cyanamid Company · 1996
- Compositions and methods for modification of biomolecules50US 8,703,936 B2The Regents of the University of California · 2014
- Tricyclic benzazepine vasopressin antagonists23US 5,747,487 AAmerican Cyanamid Company · 1998
- Enzymatic conjugation of antibodies23US 9,764,038 B2Innate Pharma · 2017